Ventyx Biosciences, Inc.
VTYX
$2.77
$0.124.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.83% | -5.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.54% | -7.16% | |||
| Operating Income | 2.54% | 7.16% | |||
| Income Before Tax | 1.65% | 6.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.65% | 6.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.65% | 6.51% | |||
| EBIT | 2.54% | 7.16% | |||
| EBITDA | 2.42% | 7.28% | |||
| EPS Basic | 1.76% | 6.92% | |||
| Normalized Basic EPS | 1.74% | 6.95% | |||
| EPS Diluted | 1.76% | 6.92% | |||
| Normalized Diluted EPS | 1.74% | 6.95% | |||
| Average Basic Shares Outstanding | 0.09% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||